In a case report of OC (OCCC inoperable at stage IIIB), resistant to platinum-based chemotherapy, the same P286R POLE mutation was found, and the third-line treatment attempt with a programmed cell death protein 1 (PD-1) inhibitor showed a tumor with postoperative pathologic complete response. The gene discussed is PDCD1; the disease is neoplasm.